```html

Paracetamol (Acetaminophen) Overdose – A Complete Medical Guide

Overview

Paracetamol, known as acetaminophen in the United States and Canada, is one of the most widely used analgesic‑antipyretic medicines worldwide. It is sold over‑the‑counter (OTC) in tablets, capsules, liquids, suppositories, and in combination products for colds, flu, and pain relief.

Why overdoses happen: The drug has a relatively narrow therapeutic window—therapeutic doses are 10–15 mg/kg per dose, while toxic doses start at about 150 mg/kg (≈10 g for a 70‑kg adult). Because the tablets look like regular “pain relievers,” people may unintentionally exceed the safe limit, especially when they take multiple products that contain paracetamol.

Who it affects: Anyone can overdose, but the highest burden falls on:

• Adults aged 25‑45 years (intentional or accidental misuse)
• Adolescents using combination cold remedies
• Patients with chronic liver disease or alcoholism (lower tolerance)
• Children who receive the wrong dose of liquid formulations

According to the World Health Organization, > 100 000 emergency department (ED) visits worldwide each year are attributable to paracetamol poisoning, making it the single most common cause of acute liver failure in many high‑income countries (CDC, 2022). In the United States, the CDC reported 55,000–70,000 annual cases of intentional overdose, with a mortality rate of 0.5–1 % when treated promptly.

Symptoms

Symptoms evolve in four classic phases. The timing depends on the amount ingested, formulation (immediate‑release vs. sustained‑release), and patient factors (fasting, liver disease).

Phase 1 (0–24 hours) – Gastro‑intestinal irritation

• Nausea & vomiting – often the first sign, may be recurrent.
• Abdominal pain – especially in the upper abdomen (right upper quadrant).
• Loss of appetite.
• Diaphoresis (sweating) and a feeling of “flu‑like” malaise.

Phase 2 (24–72 hours) – Latent/biochemical phase

• Patients may feel better, leading to a false sense of recovery.
• Laboratory abnormalities begin: rising alanine aminotransferase (ALT) and aspartate aminotransferase (AST), indicating liver cell injury.
• Possible right‑upper‑quadrant tenderness.

Phase 3 (72–96 hours) – Hepatic failure

• Jaundice – yellowing of skin and eyes.
• Coagulopathy – prolonged PT/INR, easy bruising, bleeding.
• Encephalopathy – confusion, asterixis (hand‑flap tremor), progressing to coma.
• Renal dysfunction – oliguria, elevated creatinine.

Phase 4 (>96 hours) – Recovery or death

• With timely treatment, liver enzymes fall and patients recover over 2–3 weeks.
• Severe cases may culminate in irreversible liver failure requiring transplantation.

Causes and Risk Factors

• Accidental ingestion – especially in children, or adults misreading dosing instructions.
• Intentional overdose – in suicide attempts or self‑harm.
• Polypharmacy – taking multiple OTC products (e.g., cold medicines, prescription pain meds) that contain paracetamol.
• Chronic alcohol use – induces CYP2E1 enzymes, producing a toxic metabolite (NAPQI) faster.
• Pre‑existing liver disease – hepatitis B/C, non‑alcoholic fatty liver disease (NAFLD) lower the toxic threshold.
• Fasting or malnutrition – reduces glutathione stores, decreasing the liver’s ability to detoxify NAPQI.
• Pregnancy – while safe at therapeutic doses, overdose risk is similar; maternal liver injury can affect the fetus.

Diagnosis

Diagnosis relies on a combination of clinical history, physical examination, and focused laboratory testing.

Key Steps

1. History – time of ingestion, amount (in mg or number of tablets), formulation, co‑taken substances, alcohol use.
2. Physical exam – assess for abdominal tenderness, signs of jaundice, mental status changes.

Laboratory & Imaging Tests

• Serum paracetamol concentration – drawn at least 4 hours post‑ingestion; plotted on the Rumack‑Matthew nomogram to determine need for antidote.
• Liver function tests (LFTs) – ALT, AST, bilirubin, alkaline phosphatase; rising levels signal hepatotoxicity.
• Coagulation profile – PT/INR to detect early coagulopathy.
• Renal function – BUN, creatinine, electrolytes.
• Blood glucose – hypoglycemia may occur in severe liver failure.
• Acetaminophen metabolite assay (rarely needed) – measures NAPQI‑glutathione adducts.
• Ultrasound or CT – only if other causes of abdominal pain need exclusion.

Treatment Options

Early intervention dramatically improves outcomes. Treatment is staged according to the time elapsed and the severity of toxicity.

1. Gastric Decontamination (within 1–2 hours)

• Activated charcoal 1 g/kg (max 50 g) orally – binds remaining drug in the GI tract. Contraindicated if patient is unconscious or has an unprotected airway.

2. Antidotal Therapy – N‑Acetylcysteine (NAC)

• Mechanism: Restores hepatic glutathione, detoxifies NAPQI, improves microcirculation.
• Indications:
  • Serum level above the treatment line on the Rumack‑Matthew nomogram.
  • Any symptomatic patient regardless of level.
  • Suspected massive ingestion (>150 mg/kg) even if >24 h have passed.
• Regimens:
  • IV: 150 mg/kg over 1 h → 50 mg/kg over 4 h → 100 mg/kg over 16 h (total 300 mg/kg).
  • Oral: 140 mg/kg loading dose, then 70 mg/kg every 4 h for 17 doses.
• Side effects: mild nausea, rare anaphylactoid reactions (more common with IV).

3. Supportive Care

• IV fluids to maintain perfusion.
• Monitoring: hourly vitals, mental status, urine output.
• Correction of coagulopathy with fresh frozen plasma or vitamin K when INR > 1.5.
• Management of hepatic encephalopathy – lactulose, rifaximin if indicated.
• Renal support – renal replacement therapy for acute kidney injury.

4. Advanced Interventions (for fulminant liver failure)

• Liver transplantation – evaluated when INR > 1.5, encephalopathy grade ≥ III, and no improvement after 48–72 h of NAC.
• Extracorporeal liver support – MARS (Molecular Adsorbent Recirculating System) or similar devices in some centers.

Living with Paracetamol Overdose

Even after acute management, patients may experience lingering effects or anxiety about medication use.

• Follow‑up labs – LFTs and INR should be checked at 24 h, 48 h, and 7 days post‑event.
• Avoid alcohol for at least 48 h after NAC and until liver tests normalize.
• Nutrition – a balanced diet rich in protein helps replenish glutathione stores.
• Medication review – bring all OTC and prescription meds to each visit; ask pharmacists to flag duplicate paracetamol.
• Psychological support – counseling or crisis lines for intentional overdoses can reduce repeat attempts.
• Vaccinations – hepatitis A and B vaccines if chronic liver disease is present.

Prevention

1. Read labels carefully – note the amount of paracetamol per tablet or per mL of liquid.
2. Use a dosing chart – especially for children; never estimate with household spoons.
3. Limit total daily dose – ≤ 4 g for adults (≤ 3 g for chronic alcohol users or liver disease).
4. Separate medicines – store paracetamol away from other analgesics to avoid accidental stacking.
5. Educate caregivers – ensure anyone who administers medication to a child knows the correct dose.
6. Ask health professionals before starting a new OTC product, especially if you already take a prescription pain reliever.
7. Consider “single‑ingredient” formulations – they reduce the chance of hidden paracetamol in combination drugs.

Complications

If left untreated or if treatment is delayed, several serious complications may arise:

• Acute liver failure – the most common and potentially fatal outcome.
• Acute kidney injury – due to tubular necrosis from NAPQI.
• Metabolic acidosis – can exacerbate cerebral edema.
• Septicemia – secondary infection in patients with prolonged ICU stay.
• Coagulopathy and hemorrhage – from loss of clotting factor synthesis.
• Chronic liver disease – repeated sub‑toxic exposures may accelerate fibrosis.
• Death – reported mortality 0.5–1 % in treated cases; rises to > 10 % without NAC or transplant.

When to Seek Emergency Care

---

Sources: Mayo Clinic. Acetaminophen poisoning; CDC. Drug Overdose Deaths; NIH. Acetaminophen Toxicity – Clinical Guidelines; WHO. Pharmacovigilance reports 2023; Cleveland Clinic. Acetaminophen Overdose; Rumack‑Matthew nomogram (JAMA 1975).

```